Bandingkan Harga & Kinerja Panorama Sentrawisata Tbk. (PANR) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Panorama Sentrawisata Tbk. dan Organon Pharma Indonesia Tbk.: Panorama Sentrawisata Tbk. diperdagangkan di Rp424 (kapitalisasi pasar 588,3 M, volume 24 jam 111,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Panorama Sentrawisata Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PANR | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 588,3 M | 104,4 M |
Volume | 111,8 rb | — |
Lot | 1,12 rb | — |
Perputaran | 46,5 jt | — |
Harga Rata-rata | 415,92 | — |
Nilai Transaksi | 46,5 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Panorama Sentrawisata Tbk.
PT. Panorama Sentrawisata Tbk (the Company) was established based on Notarial Deed No.71 dated July 22, 1995 and October 1995, of Sugiri Kadarisman, S.H., a public notary in Jakarta. The company has 4 divisions : 1. Inbound tours 2. Outbound Tours and Travel 3. Transportation tours 4. MICE (Meeting, Incentive, Conferences & Exhibition Organizer)
Selengkapnya di halaman PANR →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
